Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
Fuji
McKinsey
Argus Health
Federal Trade Commission
Daiichi Sankyo
Queensland Health
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: RE38628

« Back to Dashboard

Summary for Patent: RE38628
Title: Pharmaceutical compositions
Abstract:A method of treatment of a condition selected from the group comprising conjunctivitis, keratitis, `allergic eyes`, adenovirus infections, corneal homograft rejection, anterior uveitis, nasal polyps, vasomotor rhinitis, allergic manifestations of the nasopharynx, reversible obstructive airways disease, Crohn's disease, distal colitis and proctitis, which method comprises administration to a patient suffering from such a condition of a therapeutically effective amount of an aqueous solution containing, as active ingredient, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dica rboxylic acid or a pharmaceutically acceptable salt thereof. Also described are novel pharmaceutical compositions suitable for use in such methods of treatment.
Inventor(s): Clark; Andrew R. (Half Moon Bay, CA), Wright; Paul (Bramcote, GB), Ratcliffe; Julia H. (Woodbridge, GB)
Assignee: Fisons plc (Ipswich, GB)
Application Number:08/916,578
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent RE38628

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE38628

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8630767Dec 23, 1986
United Kingdom8630769Dec 23, 1986
United Kingdom8630904Dec 24, 1986
United Kingdom8706684Mar 20, 1987

International Family Members for US Patent RE38628

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 93725 ➤ Try a Free Trial
Australia 595969 ➤ Try a Free Trial
Australia 8292987 ➤ Try a Free Trial
Belgium 1002179 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Express Scripts
Cantor Fitzgerald
Cerilliant
Federal Trade Commission
Boehringer Ingelheim
Daiichi Sankyo
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.